1.48
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Yahoo Finance
Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Quantitative breakdown of Ironwood Pharmaceuticals Inc. recent moveMarket Risk Summary & Technical Buy Zone Confirmations - newser.com
Inspire Investing LLC Raises Stock Holdings in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
What is the fair value of Ironwood Pharmaceuticals Inc. stock nowJuly 2025 Chart Watch & Daily Market Momentum Tracking - newser.com
Can technical indicators confirm Ironwood Pharmaceuticals Inc.’s reversal - newser.com
Analyzing Ironwood Pharmaceuticals Inc. with risk reward ratio charts2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
News impact scoring models applied to Ironwood Pharmaceuticals Inc.2025 Sector Review & Safe Entry Zone Tips - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explainedJobs Report & Fast Entry Momentum Trade Alerts - newser.com
What does recent volatility data suggest for Ironwood Pharmaceuticals Inc.Rate Cut & Low Drawdown Momentum Trade Ideas - newser.com
Wealth Enhancement Advisory Services LLC Has $96,000 Stake in Ironwood Pharmaceuticals, Inc. $IRWD - Defense World
Is this a good reentry point in Ironwood Pharmaceuticals Inc.Quarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Applying Wyckoff theory to Ironwood Pharmaceuticals Inc. stockTrade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com
Ironwood Pharma Board Member Resigns for New Role - TipRanks
Ironwood Pharmaceuticals director Andrew Dreyfus to resign effective November 1 - Investing.com
What drives Ironwood Pharmaceuticals Inc stock priceEarnings Surprise Analysis & Start Learning With Our Courses - earlytimes.in
Weiss Ratings Reiterates Sell (E+) Rating for Ironwood Pharmaceuticals (NASDAQ:IRWD) - MarketBeat
Published on: 2025-10-09 01:18:56 - newser.com
Ironwood Pharmaceuticals Inc. stock daily chart insights2025 Technical Patterns & AI Driven Price Predictions - newser.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
How risky is Ironwood Pharmaceuticals Inc. stock nowJuly 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Reversal indicators forming on Ironwood Pharmaceuticals Inc. stockWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
What MACD and RSI say about Ironwood Pharmaceuticals Inc.2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominanceFed Meeting & Capital Efficient Trading Techniques - newser.com
Can Ironwood Pharmaceuticals Inc. hit a new high this monthJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Visualizing Ironwood Pharmaceuticals Inc. stock with heatmapsMarket Growth Report & Daily Market Momentum Tracking - newser.com
Strategies to average down on Ironwood Pharmaceuticals Inc.2025 Key Lessons & Technical Pattern Based Signals - newser.com
Will Ironwood Pharmaceuticals Inc. price bounce be sustainableShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Can momentum traders help lift Ironwood Pharmaceuticals Inc.July 2025 Rallies & High Yield Stock Recommendations - newser.com
Published on: 2025-10-03 03:28:42 - newser.com
Published on: 2025-10-01 06:27:53 - newser.com
IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down - MSN
Ironwood focuses on apraglutide amid workforce cuts - MSN
Is Ironwood Pharmaceuticals Inc. stock reversal real or fakeQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com
Top chart patterns to watch in Ironwood Pharmaceuticals Inc.Recession Risk & Real-Time Market Trend Scan - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):